Overview

Co-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM Patients

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Evaluation of the glycemic efficacy of cabergoline on diabetic patients
Phase:
Phase 3
Details
Lead Sponsor:
Sherief Abd-Elsalam
Tanta University
Treatments:
Cabergoline
Gliclazide